Sale of investment securities and recognition of an extraordinary gain
JAPAN PURE CHEMICAL CO.,LTD. (filing company)
2 listed stocks held by the Company (names: Not disclosed)
Based on the policy of improving capital efficiency and making effective use of held assets, continuously reviewing the rationale for holding cross-shareholdings and proceeding with their reduction
¥770 million (gain on sale of investment securities, extraordinary gain)
Second quarter (interim period) of the fiscal year ending March 2027
The full-year earnings forecast for the fiscal year ending March 2027 announced at the beginning of the fiscal year already includes a gain on the sale of investment securities. The impact of this sale and the recognition of the gain on the full-year earnings forecast is minor, and there is no change to the full-year earnings forecast at this time.
The Company will continue selling investment securities in line with the decision, while taking market conditions and other factors into account. It will promptly disclose any matters requiring disclosure as the sale progresses or if the earnings forecast needs to be revised.
The Company will promptly disclose any matters requiring disclosure as the sale progresses or if the earnings forecast needs to be revised.
| Item | Details |
|---|---|
| Event name | Sale of investment securities and recognition of an extraordinary gain |
| Date of occurrence | 25 August 2026 (the date on which the Board of Directors decided to sell; the actual sale date has not been specified) |
| Subject Entity | JAPAN PURE CHEMICAL CO.,LTD. (filing company) |
| Target Locations / Products | 2 listed stocks held by the Company (names: Not disclosed) |
| Cause | Based on the policy of improving capital efficiency and making effective use of held assets, continuously reviewing the rationale for holding cross-shareholdings and proceeding with their reduction |
| Amount of Impact on Business Performance | ¥770 million (gain on sale of investment securities, extraordinary gain) |
| Accounting period in which recognized | Second quarter (interim period) of the fiscal year ending March 2027 |
| Impact on Earnings Forecast | The full-year earnings forecast for the fiscal year ending March 2027 announced at the beginning of the fiscal year already includes a gain on the sale of investment securities. The impact of this sale and the recognition of the gain on the full-year earnings forecast is minor, and there is no change to the full-year earnings forecast at this time. |
| Outlook | The Company will continue selling investment securities in line with the decision, while taking market conditions and other factors into account. It will promptly disclose any matters requiring disclosure as the sale progresses or if the earnings forecast needs to be revised. |
| Planned follow-up disclosure | The Company will promptly disclose any matters requiring disclosure as the sale progresses or if the earnings forecast needs to be revised. |
Items this document does not state (15)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To improve capital efficiency and make effective use of its assets, while continuously reviewing the rationale for holding cross-shareholdings and proceeding with their reduction.